Why Kiniksa Pharmaceuticals Stock Is Falling Today
Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) is trading lower Tuesday morning after the company announced the Phase 3 trial of mavrilimumab in COVID-19-related ARDS did not meet the primary efficacy endpoint.
